A new study focused on multiple myeloma, the second most common blood cancer, may lead to better ways to group patients by ...

UCI supports the fellowship I am participating in, which focuses on preparing the next generation of clinicians for the evolving landscape of mental healthcare.’ ...

Insilico Medicine(“Insilico”), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting ...